STD Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Sexually Transmitted Diseases (STD) Diagnostics Market is segmented by Type of Disease (Chlamydia, Gonorrhea, Syphilis, Genital herpes, Hepatitis B, HIV/AIDS (Human immunodeficiency virus infection and acquired immune deficiency syndrome), Human papillomavirus (HPV), Other Diseases), Location of Diagnostic Test (Laboratory Testing and Point Of Care (PoC) Testing), By Devices (Laboratory Devices and Point of Care Devices) and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

STD Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

STD Diagnostics Industry Overview

The market for STD Diagnostics is moderately competitive in nature. Key players in the STD diagnostics market are Abbott Laboratories, MedMira Inc, Qaigen Inc, Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Diasorin S.p.A, bioMeriuex, Hologic, Inc, Bio-Rad Laboratories, Inc., amongst others. These companies focus on partnership and product/technology licensing opportunities in the sexually transmitted diseases diagnostics industry. 

STD Diagnostics Market Leaders

  1. Abbott Laboratories

  2. Diasorin S.p.A

  3. Hologic, Inc

  4. Siemens AG

  5. Cephied (Danaher Corporation)

  6. *Disclaimer: Major Players sorted in no particular order
STD Diagnostics Market Concentration